These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7874762)

  • 21. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
    Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
    Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
    Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
    Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.
    Iwafuchi H; Ito M
    Histopathology; 2019 Jan; 74(2):239-247. PubMed ID: 30062702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
    Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
    Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
    Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of utility of immunohistochemistry markers as a tool for objective diagnosis of low-grade myelodysplastic syndrome in routine reporting: Prospective observational study.
    Juneja R; Pati H; Dange P; Gupta G; Mahapatra M; Tyagi S; Saxena R
    Indian J Pathol Microbiol; 2022; 65(4):879-885. PubMed ID: 36308198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of micromegakaryocytes in de novo AML].
    Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
    Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic value of dysplasia characteristics in typing of myelodysplastic syndrome].
    Li J; Zhang M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):657-61. PubMed ID: 23815917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients.
    Kobayashi Y; Uoshima N; Kimura S; Tanaka K; Wada K; Ozawa M; Maruo N; Kondo M
    Int J Hematol; 1995 Apr; 61(3):117-22. PubMed ID: 7599323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders.
    Chuang SS; Jung YC; Li CY
    Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Multinucleated Megakaryocytes as an Isolated Finding in Bone Marrow:  A Rare Finding and Its Clinical Significance.
    Jawad MD; Go RS; Reichard KK; Shi M
    Am J Clin Pathol; 2016 Nov; 146(5):561-566. PubMed ID: 28430954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical evaluation of bone marrow biopsies in myelodysplastic syndromes.
    Soligo D; Luksch R; Quirici N; Foa P; Moneta D; Somalvico F; Lambertenghi Deliliers G
    Haematologia (Budap); 1991; 24(1):39-46. PubMed ID: 1813362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on micromegakaryocytes in myelodysplastic syndromes (MDS).
    Song YH; Qi SL; Li LQ; Yang CL
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):33-9. PubMed ID: 3174614
    [No Abstract]   [Full Text] [Related]  

  • 34. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunocytochemical detection of normal and abnormal megakaryocytes using monoclonal antibody to glycoprotein IIb-IIIa (TP80): the quantitative assay in normal and in leukaemic patients.
    Sato T; Shichishima T; Kimura H; Uchida T; Kariyone S; Ohto H; Maeda H
    Scand J Haematol; 1986 May; 36(5):415-23. PubMed ID: 2943015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome.
    Zheng G; He R; Reichard KK; Peterson JF; Olteanu H; Oliveira JL; Rangan A; Chen D; Shi M
    Am J Surg Pathol; 2021 Nov; 45(11):1534-1540. PubMed ID: 33999554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow biopsy of aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders.
    Kikuchi M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1339-46. PubMed ID: 3247814
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears.
    Tricot G; De Wolf-Peeters C; Hendrickx B; Verwilghen RL
    Br J Haematol; 1984 Jul; 57(3):423-30. PubMed ID: 6589011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.